The FDA has announced that it has approved a new drug to treat chronic idiopathic constipation and to treat irritablebowelsyndrome with constipation (IBS-C) in adults.
It could catapult past the billion-dollar mark by the aiding millions of people with the indigestion, constipation, stomach pain and other severe symptoms known by the catchall term "irritable bowelsyndrome" (ibs).